Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.54
0.03 (1.99%)
At close: Aug 15, 2025, 3:09 PM

Pulmonx Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
70.91M 83.55M 101.74M 148.48M
Short-Term Investments
30.58M 33.55M 39.4M 31.56M
Long-Term Investments
n/a 14.39M 5.92M 10.94M
Other Long-Term Assets
2.82M 3.17M 5.4M 252K
Receivables
13.79M 13.02M 8.68M 6.56M
Inventory
16.91M 16.74M 14.56M 16.29M
Other Current Assets
1.39M 741K 521K 578K
Total Current Assets
136.25M 150.42M 168.95M 208M
Property-Plant & Equipment
21.45M 7.43M 10.5M 12.89M
Goodwill & Intangibles
2.33M 2.36M 2.49M 2.61M
Total Long-Term Assets
26.6M 27.36M 24.72M 27.17M
Total Assets
162.85M 177.78M 193.68M 235.17M
Account Payables
3.83M 1.5M 1.76M 1.58M
Deferred Revenue
135K 104K 120K 163K
Short-Term Debt
3.18M 2.15M 3.32M 91K
Other Current Liabilities
16.52M 7.88M 4.45M 4.63M
Total Current Liabilities
24.44M 23.16M 18.49M 17.55M
Long-Term Debt
34M 35.09M 21.08M 17.32M
Other Long-Term Liabilities
18.52M n/a -3.85M 179K
Total Long-Term Liabilities
52.6M 36.31M 21.18M 24.38M
Total Liabilities
77.04M 59.47M 39.67M 41.93M
Total Debt
56.47M 41.42M 24.4M 26.46M
Common Stock
40K 39K 38K 37K
Retained Earnings
-467.56M -411.16M -350.32M -291.39M
Comprehensive Income
2.11M 2.64M 1.57M 1.71M
Shareholders Equity
85.81M 118.31M 154.01M 193.24M
Total Investments
30.58M 47.95M 45.33M 42.5M